Christopher Mutz - Net Worth and Insider Trading
Christopher Mutz Net Worth
The estimated net worth of Christopher Mutz is at least $5 Million dollars as of 2024-06-20. Christopher Mutz is the HEAD OF RARE DISEASE of ANI Pharmaceuticals Inc and owns about 83,277 shares of ANI Pharmaceuticals Inc (ANIP) stock worth over $5 Million. Details can be seen in Christopher Mutz's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Christopher Mutz has not made any transactions after 2024-05-21 and currently still holds the listed stock(s).
Transaction Summary of Christopher Mutz
Christopher Mutz Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Christopher Mutz owns 1 companies in total, including ANI Pharmaceuticals Inc (ANIP) .
Click here to see the complete history of Christopher Mutz’s form 4 insider trades.
Insider Ownership Summary of Christopher Mutz
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ANIP | ANI Pharmaceuticals Inc | 2024-05-21 | HEAD OF RARE DISEASE |
Christopher Mutz Latest Holdings Summary
Christopher Mutz currently owns a total of 1 stock. Christopher Mutz owns 83,277 shares of ANI Pharmaceuticals Inc (ANIP) as of May 21, 2024, with a value of $5 Million.
Latest Holdings of Christopher Mutz
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ANIP | ANI Pharmaceuticals Inc | 2024-05-21 | 83,277 | 59.67 | 4,969,139 |
Holding Weightings of Christopher Mutz
Christopher Mutz Form 4 Trading Tracker
According to the SEC Form 4 filings, Christopher Mutz has made a total of 3 transactions in ANI Pharmaceuticals Inc (ANIP) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in ANI Pharmaceuticals Inc is the sale of 2,000 shares on May 21, 2024, which brought Christopher Mutz around $123,220.
Insider Trading History of Christopher Mutz
- 1
Christopher Mutz Trading Performance
Christopher Mutz Ownership Network
Christopher Mutz Owned Company Details
What does ANI Pharmaceuticals Inc do?
Who are the key executives at ANI Pharmaceuticals Inc?
Christopher Mutz is the HEAD OF RARE DISEASE of ANI Pharmaceuticals Inc. Other key executives at ANI Pharmaceuticals Inc include SR. VP & GENERAL COUNSEL & SEC. Meredith Cook , SVP & GENERICS Ori Gutwerg , and Vice President and CFO Stephen P. Carey .
ANI Pharmaceuticals Inc (ANIP) Insider Trades Summary
Over the past 18 months, Christopher Mutz made 3 insider transaction in ANI Pharmaceuticals Inc (ANIP) with a net sale of 10,000. Other recent insider transactions involving ANI Pharmaceuticals Inc (ANIP) include a net sale of 676,190 shares made by Muthusamy Shanmugam , a net sale of 180,000 shares made by Chad Gassert , and a net sale of 2,000 shares made by Meredith Cook .
In summary, during the past 3 months, insiders sold 189,404 shares of ANI Pharmaceuticals Inc (ANIP) in total and bought 0 shares, with a net sale of 189,404 shares. During the past 18 months, 1,290,262 shares of ANI Pharmaceuticals Inc (ANIP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,290,262 shares.
ANI Pharmaceuticals Inc (ANIP)'s detailed insider trading history can be found in Insider Trading Tracker table.
ANI Pharmaceuticals Inc Insider Transactions
Christopher Mutz Mailing Address
Above is the net worth, insider trading, and ownership report for Christopher Mutz. You might contact Christopher Mutz via mailing address: C/o Ani Pharmaceuticals, Inc., 210 Main Street West, Baudette Mn 56623.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
